Nociceptive Monitoring With Skin Conductance and Nol-index in Moderate-to-high Risk Cardiovascular Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Analgesia
- Sponsor
- Erasme University Hospital
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- Nol-Index response
- Last Updated
- 5 years ago
Overview
Brief Summary
Comparison of twà different nociception monitors during general anesthesia
Detailed Description
Analgesia remains a challenge in anesthesia. Several monitors have shown potential in detecting insufficient analgesia during general anesthesia, but they have not been investigated in patients undergoing cardiac and vascular surgery. In this study, we will compare skin conductance (Medstorm, Norway) and nol-index (Medasense, Israel) w during noxious and non-noxious stimuli. This study is carried out on patients included in another study (Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery).
Investigators
Eligibility Criteria
Inclusion Criteria
- •moderate-to-high risk cardiac or vascular surgery
Exclusion Criteria
- •chronic arrhythmia (e.g. atrial fibrillation)
- •aortic insufficiency
- •pacemaker
- •implanted defibrillator
- •valve surgery
Outcomes
Primary Outcomes
Nol-Index response
Time Frame: 1 to 2 hours
Nol-Index (diminsenliss value from 0 to 100) will be assessed during noxious and non noxious stimuli
Skin conductance response
Time Frame: 1 to 2 hours
Peaks per second change during noxious and non noxious stimuli